Venatorx Pharmaceuticals, Inc.
8 clinical trials · Sponsor
◉ Watch Venatorx Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP (NCT06168734) | Venatorx Pharmaceuticals, Inc. | 2025-06-01 |
| Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects (NCT04951505) | Venatorx Pharmaceuticals, Inc. | 2021-06-29 |
| VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers (NCT04845321) | Venatorx Pharmaceuticals, Inc. | 2021-06-23 |
| Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections (NCT03840148) | Venatorx Pharmaceuticals, Inc. | 2019-08-07 |
| Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects (NCT03870490) | Venatorx Pharmaceuticals, Inc. | 2019-03-14 |
| VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment (NCT03690362) | Venatorx Pharmaceuticals, Inc. | 2018-04-06 |
| VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers (NCT03332732) | Venatorx Pharmaceuticals, Inc. | 2017-10-24 |
Track Venatorx Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.